Keloids are transcriptionally distinct from normal and hypertrophic scars
- PMID: 38465540
- DOI: 10.1684/ejd.2023.4582
Keloids are transcriptionally distinct from normal and hypertrophic scars
Abstract
Wound healing and skin regeneration after injury are complex biological processes, and deep injuries with a high degree of tissue destruction may result in severe scar formation. Clinically, scars can be classified into normal, hypertrophic and keloid scars. However, the molecular signature of each scar type is currently not known. The aim of this study was to reveal the transcriptional landscape of normal, hypertrophic and keloid skin scars following hand and plastic surgery based on total RNA sequencing. Eighteen skin scar samples from hand and plastic surgeries of human donors were minced directly after removal and stored in TRIzol (Thermo Fisher, USA). Samples were then subjected to RNA isolation, cDNA library preparation, bulk RNA sequencing and bioinformatics analysis. We show that keloid scars transcriptionally differed from normal and hypertrophic scars. Normal and hypertrophic scars presented overlapping clustering, and eight genes were shown to be commonly expressed between hypertrophic and normal scars. No genes were specifically expressed at a higher level in keloid and normal scars. Based on gene ontology pathway analysis, genes with a higher level of expression in keloid scars lead to increased (extra-) cellular matrix proliferation and cell interaction. Moreover, tumour-like genes were more highly expressed in keloid scars, supporting the clinical impression of strong and diffuse growth. This study furthers our understanding of the classification of differential scar types based on molecular signature, which may shed light on new diagnostic and therapeutic strategies for keloid scars in the future.
Keywords: RNA sequencing; hand surgery; hypertrophic scar; keloids; skin scar; wound healing.
Similar articles
-
Tension-sensitive HOX gene expression in fibroblasts for differential scar formation.J Transl Med. 2025 Feb 10;23(1):168. doi: 10.1186/s12967-025-06191-1. J Transl Med. 2025. PMID: 39930512 Free PMC article.
-
Hypertrophic and keloid scars fail to progress from the CD34- /α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression.Br J Dermatol. 2020 Apr;182(4):974-986. doi: 10.1111/bjd.18219. Epub 2019 Sep 4. Br J Dermatol. 2020. PMID: 31206605
-
Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.Med Hypotheses. 2016 Nov;96:51-60. doi: 10.1016/j.mehy.2016.09.024. Epub 2016 Sep 28. Med Hypotheses. 2016. PMID: 27959277
-
Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.Int J Mol Sci. 2017 Mar 10;18(3):606. doi: 10.3390/ijms18030606. Int J Mol Sci. 2017. PMID: 28287424 Free PMC article. Review.
-
Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.J Cell Physiol. 2019 Dec;234(12):21662-21669. doi: 10.1002/jcp.28830. Epub 2019 May 20. J Cell Physiol. 2019. PMID: 31106425 Review.
Cited by
-
Adipose stem cell exosomes promote mitochondrial autophagy through the PI3K/AKT/mTOR pathway to alleviate keloids.Stem Cell Res Ther. 2024 Sep 15;15(1):305. doi: 10.1186/s13287-024-03928-5. Stem Cell Res Ther. 2024. PMID: 39278919 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources